178 related articles for article (PubMed ID: 15847740)
1. [Multiple pulmonary nodules and amiodarone. KL-6 as a new diagnostic tool].
Bernal Morell E; Hernández Madrid A; Marín Marín I; Rodríguez Pena R; González Gordaliza MC; Moro C
Rev Esp Cardiol; 2005 Apr; 58(4):447-9. PubMed ID: 15847740
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic usefulness of KL-6 measurements in patients with pulmonary complications after administration of amiodarone].
Endoh Y; Hanai R; Uto K; Uno M; Nagashima H; Takizawa T; Narimatsu A; Ohnishi S; Kasanuki H
J Cardiol; 2000 Feb; 35(2):121-7. PubMed ID: 10713933
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
Kohno N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
5. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980
[TBL] [Abstract][Full Text] [Related]
7. KL-6 as a serum marker for amiodarone-induced pulmonary toxicity.
Kohno N; Yokoyama A; Kondo K
Intern Med; 2000 Dec; 39(12):1004-5. PubMed ID: 11197780
[No Abstract] [Full Text] [Related]
8. Serum KL-6 level and pulmonary function in preterm infants with chronic lung disease.
Yamane M; Yokoyama N
Kobe J Med Sci; 2004; 50(5-6):131-40. PubMed ID: 16049353
[TBL] [Abstract][Full Text] [Related]
9. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
[TBL] [Abstract][Full Text] [Related]
10. Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity.
Nakajima M; Kawahara Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
Intern Med; 2000 Dec; 39(12):1097-100. PubMed ID: 11197799
[TBL] [Abstract][Full Text] [Related]
11. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
[TBL] [Abstract][Full Text] [Related]
12. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
13. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
Kohno N
J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
[TBL] [Abstract][Full Text] [Related]
14. SP-D as a marker of amiodarone-induced pulmonary toxicity.
Umetani K; Abe M; Kawabata K; Iida T; Kohno I; Sawanobori T; Kugiyama K
Intern Med; 2002 Sep; 41(9):709-12. PubMed ID: 12322797
[TBL] [Abstract][Full Text] [Related]
15. Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT.
Kinoshita F; Hamano H; Harada H; Kinoshita T; Igishi T; Hagino H; Ogawa T
Respir Med; 2004 Nov; 98(11):1131-7. PubMed ID: 15526815
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia].
Kobayashi J; Itoh Y; Kitamura S; Kawai T
Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361
[TBL] [Abstract][Full Text] [Related]
18. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.
Ohshimo S; Yokoyama A; Hattori N; Ishikawa N; Hirasawa Y; Kohno N
Biochem Biophys Res Commun; 2005 Dec; 338(4):1845-52. PubMed ID: 16289035
[TBL] [Abstract][Full Text] [Related]
19. Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome.
Kase S; Kitaichi N; Namba K; Miyazaki A; Yoshida K; Ishikura K; Ikeda M; Nakashima T; Ohno S
Am J Kidney Dis; 2006 Dec; 48(6):935-41. PubMed ID: 17162148
[TBL] [Abstract][Full Text] [Related]
20. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis.
Janssen R; Sato H; Grutters JC; Bernard A; van Velzen-Blad H; du Bois RM; van den Bosch JM
Chest; 2003 Dec; 124(6):2119-25. PubMed ID: 14665489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
